NSTM (NovelStem International) PE Ratio (TTM): 0.19 (As of Jul. 31, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is NovelStem International PE Ratio (TTM)?

NovelStem International NSTM PE Ratio (TTM) is 0.19 as of Jul. 31, 2026. The stock has 2 warning signs investors should review. Among 94 Medical Diagnostics & Research companies, NovelStem International ranks better than 98.94% on this metric.

The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2026-07-31), NovelStem International's share price is $0.01146. NovelStem International's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $0.06. Therefore, NovelStem International's PE Ratio (TTM) for today is 0.19.


The historical rank and industry rank for NovelStem International's PE Ratio (TTM) or its related term are showing as below:

NSTM' s PE Ratio (TTM) Range Over the Past 10 Years
Min: At Loss   Med: At Loss   Max: 0.19
Current: 0.19


During the past 13 years, the highest PE Ratio (TTM) of NovelStem International was 0.19. The lowest was 0.00. And the median was 0.00.


NSTM's PE Ratio (TTM) is ranked better than
98.94% of 94 companies
in the Medical Diagnostics & Research industry
Industry Median: 32.445 vs NSTM: 0.19

NovelStem International's Earnings per Share (Diluted) for the three months ended in Mar. 2026 was $0.00. Its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $0.06.

As of today (2026-07-31), NovelStem International's share price is $0.01146. NovelStem International's EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 was $0.00. Therefore, NovelStem International's PE Ratio without NRI for today is N/A.

NovelStem International's EPS without NRI for the three months ended in Mar. 2026 was $0.00. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 was $0.00.

NovelStem International's EPS (Basic) for the three months ended in Mar. 2026 was $0.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was $0.06.


NovelStem International  (OTCPK:NSTM) PE Ratio (TTM) Explanation

The PE Ratio (TTM) can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio (TTM) is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio (TTM) is positive. Also for stocks with the same PE Ratio (TTM), the one with faster growth business is more attractive.

If a company loses money, the PE Ratio (TTM) becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio (TTM) divided by the growth ratio. He thinks a company with a PE Ratio (TTM) equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio (TTM) of 20, instead of a company growing 10% a year with a PE Ratio (TTM) of 10.

Because the PE Ratio (TTM) measures how long it takes to earn back the price you pay, the PE Ratio (TTM) can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio without NRI or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio (TTM) measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio (TTM) can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio (TTM)s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio (TTM) is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio .

PE Ratio (TTM) can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio (TTM).


NovelStem International PE Ratio (TTM) Related Terms


NovelStem International PE Ratio (TTM) Historical Data

* Premium members only.

The historical data trend for NovelStem International's PE Ratio (TTM) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NovelStem International PE Ratio (TTM) Chart

NovelStem International Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec21 Dec22 Dec23 Dec24 Dec25
PE Ratio (TTM)
Get a 7-Day Free Trial Premium Member Only Premium Member Only At Loss At Loss At Loss At Loss 0.18

NovelStem International Quarterly Data
Sep13 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
PE Ratio (TTM) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only At Loss 2.66 0.46 0.18 0.16

NSTM vs NOTVQ, PRPH, IDTA: PE Ratio (TTM) Comparison

For the Diagnostics & Research subindustry, NovelStem International's PE Ratio (TTM), along with its competitors' market caps and PE Ratio (TTM) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NovelStem International PE Ratio (TTM) vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, NovelStem International's PE Ratio (TTM) distribution charts can be found below:

* The bar in red indicates where NovelStem International's PE Ratio (TTM) falls into.



NovelStem International PE Ratio (TTM) Calculation

The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.

NovelStem International's PE Ratio (TTM) for today is calculated as

PE Ratio (TTM)=Share Price/Earnings per Share (Diluted) (TTM)
=0.01146/0.060
=0.19

NovelStem International's Share Price of today is $0.01146.
NovelStem International's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.06.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PE Ratio (TTM)=Market Cap /Net Income

There are at least three kinds of PE Ratio (TTM)s used by different investors. They are Trailing Twelve Month PE Ratio (TTM) or PE Ratio (TTM) (TTM), Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio (TTM) based on inflation-adjusted normalized PE Ratio (TTM) is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.

Frequently Asked Questions Learn more about PE Ratio (TTM) →
What does a PE Ratio (TTM) of 0.19 mean?
NovelStem International (NSTM) has a PE Ratio (TTM) of 0.19 as of Jul. 31, 2026. Trailing 12-month P/E ratio is the ratio of share price to a company's trailing 12-month earnings per share. View historical data on NovelStem International and its competitors. According to the industry distribution chart, NovelStem International ranks #1 out of 94 companies in the Medical Diagnostics & Research industry, placing it in the top 1.1%.
Is NovelStem International's PE Ratio (TTM) too high?
NovelStem International's current PE Ratio (TTM) is 0.19. The Medical Diagnostics & Research industry median PE Ratio (TTM) is 32.45. NovelStem International's value of 0.19 is 99.4% below this industry median. Based on the distribution chart, NovelStem International ranks #1 out of 94 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers.
How does NovelStem International's PE Ratio (TTM) compare to NOTVQ and PRPH?
According to the Medical Diagnostics & Research industry distribution chart, NovelStem International ranks #1 out of 94 companies for PE Ratio (TTM). This places NovelStem International in the top 1% of its industry — outperforming the majority of peers. The industry median PE Ratio (TTM) is 32.45. NovelStem International's value of 0.19 is 99.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio (TTM) for a Medical Diagnostics & Research company?
The median PE Ratio (TTM) among Medical Diagnostics & Research companies is 32.45, based on 94 companies in the industry. Companies in the top quartile (top 25%) have a PE Ratio (TTM) significantly above this median, while those in the bottom quartile fall well below. However, PE Ratio (TTM) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. NovelStem International's current PE Ratio (TTM) of 0.19 is 99.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio (TTM) mean?
A high PE Ratio (TTM) can signal that a stock is expensive relative to its fundamentals. Trailing 12-month P/E ratio is the ratio of share price to a company's trailing 12-month earnings per share. View historical data on NovelStem International and its competitors. For the Medical Diagnostics & Research industry, the median PE Ratio (TTM) is 32.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NovelStem International's current PE Ratio (TTM) is 0.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NovelStem International stock overvalued right now?
NovelStem International (NSTM) has a current PE Ratio (TTM) of 0.19. The current PE Ratio (TTM) is 0.19 and 99.4% below the Medical Diagnostics & Research industry median of 32.45. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio (TTM) calculated?
PE Ratio (TTM) is calculated from a company's financial statements. For NovelStem International (NSTM), the current PE Ratio (TTM) is 0.19 as of Jul. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

NovelStem International Business Description

Address 7740 Cavern Lane, Suite 100, Parkland, FL, USA, 33067
NovelStem International Corp is a holding company. Through its subsidiaries, the company is engaged in the development and commercialization of diagnostic technology that can predict patients' anti-cancer drug resistance, allowing for targeted cancer treatments and the potential to reduce resistance to chemotherapy. The company also has an interest in a book publishing franchise.